Onxeo SA
Overview
Onxeo SA is a clinical-stage biotechnology company specializing in the development of innovative drugs for oncology. The company is focused on the development of unique therapeutic options aimed at improving cancer treatment outcomes using a diversified approach.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Onxeo SA in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.